精神病风险中的白质改变与发育相关且不受转归影响
研究基于NAPLS-3纵向队列,对286名12-32岁受试者(25名转为精神病CHR-P、205名转归未知CHR-U、56名健康对照)进行多时间点多壳扩散磁共振成像,采用线性混合效应模型分析白质微结构随年龄的变化。基线白质指标不能区分三组,但年龄轨迹存在发育性差异:CHR-P与CHR-U青少年期FAT较高,30岁时较对照低4%;20岁以上CHR-P在major forceps的FW高4%(p<0.05)。前瞻分析未发现疾病发作对FAT或FW有显著影响,提示转为精神病并不伴随白质微结构的剧烈变化,高危状态本身与年龄相关的细微白质改变并行。
要点
- 基线白质微结构无法区分健康对照、CHR-U与CHR-P个体。
- 高危个体的白质年龄轨迹呈发育性差异,而非疾病发作驱动。
- 转为精神病未伴随区域FAT或FW的显著变化。
核心结论
- 临床高精神病风险个体的白质微结构改变与年龄发育轨迹相关,而非由转为精神病这一事件驱动。
- 基线白质指标不能区分CHR-P、CHR-U与健康对照。
- 转为精神病并未伴随白质微结构的剧烈变化。
研究设计与样本
- 北美前驱期纵向研究(NAPLS-3)纵向队列,多时间点(1年内1-5次)多壳扩散磁共振成像。
- 共286名12-32岁受试者:25名CHR-P(61次扫描)、205名CHR-U(596次扫描)、56名健康对照(195次扫描)。
- 采用线性混合效应模型推断年龄与疾病发作对细胞组织分数各向异性(FAT)与细胞外自由水体积分数(FW)变异的影响。
主要发现
- 基线白质微结构指标在三组间无差异。
- CHR-P与CHR-U组青少年期FAT较高,30岁时较对照低4%。
- 20岁以上CHR-P个体在major forceps的FW高4%(p<0.05)。
- CHR-P前瞻分析未显示疾病发作对区域FAT或FW有显著影响。
临床怎么用
- 解读高危个体白质影像时应考虑年龄发育轨迹,而非仅关注是否转为精神病。
- 基线白质指标目前不足以用于区分高危个体的转归。
- 临床随访中白质细微改变可能反映发育过程,需结合年龄解释。
局限性
- 205名CHR-U个体在1年随访后转归未知,可能影响转归相关比较。
- 随访时间仅1年,长期发育轨迹与转归关系尚不明确。
- 样本中转为精神病者仅25名,CHR-P相关分析统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Subtle alterations in white matter microstructure are observed in youth at clinical high risk (CHR) for psychosis. However, the timing of these changes and their relationships to the emergence of psychosis remain unclear. Here, we track the evolution of white matter abnormalities in a large, longitudinal cohort of CHR individuals comprising the North American Prodrome Longitudinal Study (NAPLS-3). Multi-shell diffusion magnetic resonance imaging data were collected across multiple timepoints (1-5 over 1 year) in 286 subjects (aged 12-32 years): 25 CHR individuals who transitioned to psychosis (CHR-P; 61 scans), 205 CHR subjects with unknown transition outcome after the 1-year follow-up period (CHR-U; 596 scans), and 56 healthy controls (195 scans). Linear mixed effects models were fitted to infer the impact of age and illness-onset on variation in the fractional anisotropy of cellular tissue (FAT) and the volume fraction of extracellular free water (FW). Baseline measures of white matter microstructure did not differentiate between HC, CHR-U and CHR-P individuals. However, age trajectories differed between the three groups in line with a developmental effect: CHR-P and CHR-U groups displayed higher FAT in adolescence, and 4% lower FAT by 30 years of age compared to controls. Furthermore, older CHR-P subjects (20+ years) displayed 4% higher FW in the forceps major (p < 0.05). Prospective analysis in CHR-P did not reveal a significant impact of illness onset on regional FAT or FW, suggesting that transition to psychosis is not marked by dramatic change in white matter microstructure. Instead, clinical high risk for psychosis-regardless of transition outcome-is characterized by subtle age-related white matter changes that occur in tandem with development.
引用
- Di Biase MA, Cetin-Karayumak S, Lyall AE, et al. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Mol Psychiatry. 2021. PMID: 34024906. doi:10.1038/s41380-021-01128-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。